image
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - CA
$ 2.345
-8.04 %
$ 4.69 M
Market Cap
-0.02
P/E
BALANCE SHEET
27.3 M ASSETS
-6.49%
6.14 M LIABILITIES
-19.39%
21.2 M EQUITY
-1.94%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Sunshine Biopharma, Inc.
image
Current Assets 24.9 M
Cash & Short-Term Investments 16.3 M
Receivables 2.55 M
Other Current Assets 6.05 M
Non-Current Assets 2.46 M
Long-Term Investments 0
PP&E 1.01 M
Other Non-Current Assets 1.44 M
Current Liabilities 5.55 M
Accounts Payable 2.59 M
Short-Term Debt 119 K
Other Current Liabilities 2.85 M
Non-Current Liabilities 588 K
Long-Term Debt 539 K
Other Non-Current Liabilities 48.7 K

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Jul-2008 Jul-2007
ASSETS
Cash & Cash Equivalents 16.3 21.8 2.0 1.0 40.5 K 0.1 0.1 57.5 K 50.8 K 0.1 31.2 K 0.1 60.7 K 0.2 0.1 4.36 K 14.9 K
Short Term Investments 0 0 7.59 K 7.59 K 7.59 K 0 0 0 0 0 0 0 0 0 0 0 0
Receivables 2.6 1.9 7.8 K 1.92 K 430 0 0 0 3.11 K 0 0 0 0 0 0 0 0
Inventory 5.7 3.3 0.1 23.8 K 15.9 K 0 9.67 K 0 3.11 K 0 0 0 0 0 0 0 0
Other Current Assets 0.3 0.3 37.2 K 10.4 K 8.84 K 1.0 9.67 K 2.01 K 3.11 K 0 0 2.16 K 45.7 K 45.2 K 0 667 0
Total Current Assets 24.9 27.3 2.2 1.0 65.7 K 0.2 0.1 58.5 K 53.9 K 0.1 31.2 K 0.1 0.1 0.2 0.1 5.03 K 14.9 K
PP&E 1.0 1.2 7.06 K 19.5 K 32.5 K 0.3 60 K 5.94 K 4.31 K 0 0 0 0 0 0 0 0
Intangible Assets 1.4 0.8 0 0 0 0 0 0 0.6 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0.7 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 1.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 0 (1.9) 7.06 K 19.5 K 32.5 K 0 80.3 K 0 0 0 0 0 0 0 0 0 0
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 667 0
Total Assets 27.3 29.2 2.2 1.0 98.1 K 1.1 0.3 64.4 K 0.7 0.1 31.2 K 0.1 0.1 0.2 0.1 5.03 K 14.9 K
LIABILITIES
Accounts Payable 2.6 2.8 42.9 K 62.9 K 96.9 K 0.1 19.3 K 28.1 K 46.6 K 34.8 K 23.8 K 595 3.43 K 11.4 K 14.3 K 5.21 K 1.5 K
Short Term Debt 0.1 3.8 0 1.0 0.7 0.7 0.7 0.2 1.1 0.5 12.5 K 62.5 K 0 0 0 17 K 0
Other Current Liabilities 2.5 0 48.3 K 24.3 K 21.1 K 0.1 9.22 K 9.01 K 83.1 K 16.1 K 2.64 K 0 0 0 0 0 0
Total Current Liabilities 5.6 6.9 91.2 K 1.1 0.8 0.9 0.8 0.3 1.3 0.5 39 K 64.4 K 3.43 K 11.4 K 14.3 K 22.7 K 1.5 K
Long Term Debt 0.5 0.6 1.9 0.9 0 0.3 79.7 K 0 0 0 0 0 0 0 0 0 0
Deferred Tax Income 48.7 K 43 K 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Liabilities 6.1 7.6 2.0 2.0 0.8 1.2 0.8 0.3 1.3 0.5 39 K 64.4 K 3.43 K 11.4 K 14.3 K 22.7 K 1.5 K
EQUITY
Common Stock 28 K 22.6 K 2.59 K 0.3 35.3 K 85.7 K 0.9 0.8 0.2 73.6 K 60.3 K 51.4 K 48.7 K 30.7 K 29.7 K 9.39 K 9.39 K
Retained Earnings (63.9) (59.4) (32.7) (20.2) (17.4) (15.8) (13.6) (12.6) (9.1) (7.4) (5.5) (3.0) (2.3) (1.7) (1.2) 44.2 K 13.1 K
Other Accumulative Comprehensive Income/Loss 0.7 0.2 23.1 K 2.87 K 2.5 K 3.74 K 504 394 740 0 0 0 0 0 0 0 0
Total Equity 21.2 21.6 0.2 (1.0) (0.7) 55.8 K (0.6) (0.2) (0.6) (0.4) 7.71 K 70.4 K 0.1 0.2 97.8 K 17.7 K 13.4 K
Total Liabilities and Equity 27.3 29.2 2.2 1.0 98.1 K 1.1 0.3 64.4 K 0.7 0.1 31.2 K 0.1 0.1 0.2 0.1 5.03 K 14.9 K
SHARES OUTSTANDING
Common Shares Outstanding 12.2 K 7.59 K 1.31 K 866 1.76 K 15.2 K 43.6 K 21.2 K 1.53 K 3.68 K 3.01 K 2.57 K 2.44 K 1.53 K 23.5 K 468 468